Rapamycin has been shown to remove progeria via improved autophagy and reduce senescence in patients with Hutchinson-Gilford progeria syndrome, as inhibition of the mTOR pathway can lengthen life expectancy in mice [218]. Here, MTOR is linked to progeroid syndrome.